FAM20A and embryonal carcinoma: Consistent with this possibility, it has been reported that FAM20A was downregulated by 3.8-fold when a bulk of LTR5_Hs copies were altered to have a repressive modification in human embryonal carcinoma cells, using the CRISPRi system (Fuentes et al. 2018).